{"disease":{"id":"skin-structures-and-soft-tissue-infections","name":"skin structures and soft tissue infections"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02600611","title":"Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"Motif Bio","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}